Vincenza Nigro
Corporate Officer/Principal presso HANSA BIOPHARMA AB
Profilo
Vincenza Nigro is currently the Vice President-Global Medical Affairs at Hansa Biopharma AB since 2018.
Prior to this, she was the Head-Medical Affairs at Veloxis Pharmaceuticals A.
Nigro holds an MBA from the Massachusetts Institute of Technology and an undergraduate degree from Fairleigh Dickinson University.
Posizioni attive di Vincenza Nigro
| Società | Posizione | Inizio |
|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17/09/2018 |
Precedenti posizioni note di Vincenza Nigro
| Società | Posizione | Fine |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | - |
Formazione di Vincenza Nigro
| Massachusetts Institute of Technology | Masters Business Admin |
| Fairleigh Dickinson University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Vincenza Nigro
